FindTrial
Sign In

Refresh Tears

DRUG7 trials

Sponsors

Pharmaceutical Research Network, University of Colorado, Denver, University of South Alabama, North Texas Institute for Clinical Trials, Alcon Research

Conditions

BlindnessDry EyeDry Eye SyndromesHistamine Responsive Allergy PatientsOcular HypertensionOpen Angle GlaucomaRetinal DetachmentRetinopathy of Prematurity

Phase 4

Soothe Versus Refresh
CompletedNCT00284999
Pharmaceutical Research NetworkDry Eye Syndromes
End: 2006-08-31Target: 33Updated: 2006-08-22
Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity
TerminatedNCT00634972
University of South AlabamaBlindness, Retinal Detachment, Retinopathy of Prematurity
Start: 2005-11-30End: 2008-08-31Updated: 2020-12-08
The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing
CompletedNCT01128556
North Texas Institute for Clinical TrialsHistamine Responsive Allergy Patients
Start: 2010-04-30End: 2010-06-30Target: 30Updated: 2010-07-08
Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
NCT01382810
Innovative MedicalDry Eye Syndromes
Start: 2011-03-31End: 2012-10-31Target: 100Updated: 2012-06-14

Unknown Phase

Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells
TerminatedNCT00478036
University of Colorado, DenverOpen Angle Glaucoma
Start: 2007-05-31End: 2014-01-31Updated: 2016-10-07
To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye Drops
CompletedNCT01160133
Alcon ResearchDry Eye
Start: 2010-07-31End: 2011-06-30Updated: 2012-04-10
Prophylaxis for Anti-VEGF-induced IOP Elevation
WithdrawnNCT02623023
McMaster UniversityOcular Hypertension
Start: 2019-01-01End: 2019-01-01Updated: 2023-05-22